home

Exploiting breast tumor cells’ survival mechanism to stem tumor growth

Frontierharvard2016-04-21 09:58 Read   85

Cancer cells often devise ways to survive even in the presence of toxic chemotherapy.

Brigham researchers demonstrate a systemic Trojan Horse approach for prostate cancer

R&Dfiercebiotech2016-04-21 09:54 Read   88

Gaining the ability to target a chemotherapy drug specifically to tumor cells, leaving healthy neighboring cells unscathed, is a long-standing goal in the field of cancer therapy.

Duke scientists crystallize protein, unlocking new antibiotic development window

Trendfiercebiotech2016-04-21 09:50 Read   88

Cara Therapeutics, Inc. (CARA), today announced that it has received notice from the U.S. Food and Drug Administration (FDA) that it has removed the clinical hold on its adaptive Phase 3 trial of I.V. CR845 for postoperative pain.

Cara Therapeutics Announces Removal of FDA Clinical Hold on CLIN3001 Postoperative Pain Trial for I.V. CR845

TrendYAHOO2016-04-21 09:35 Read   103

Cara Therapeutics, Inc. (CARA) today announced that it has received notice from the U.S. Food and Drug Administration (FDA) that it has removed the clinical hold on its adaptive Phase 3 trial of I.V. CR845 for postoperative pain.

SBP and GSK Create New Center for Translational Neuroscience

Frontiermarketwired2016-04-21 09:29 Read   73

Academic-Industry Alliance Seeks to Find and Validate New Targets for Drug Development

Medrio and Clinartis Announce New Partnership

EVENTSmarketwired2016-04-21 09:23 Read   58

Medrio, a leading Software as a Service (SaaS) company providing cloud-based data management capabilities to clinical researchers, and Clinartis, a contract research organization (CRO) providing clinical trial services in the United States and Europe, have announced a new partnership under Medrio's Partner Program.

LabCorp Said to Have Held Talks With INC Research Holdings

EVENTSbloomberg2016-04-21 09:15 Read   75

Laboratory Corp. of America Holdings has held talks with INC Research Holdings Inc. about a possible deal, according to people with knowledge of the matter, as it seeks to solidify its position as the biggest diagnostics company in the U.S.

China FDA slams 3 drugmakers on manufacturing lapses

Regulatorfiercepharma2016-04-20 16:57 Read   94

China FDA has ordered 3 drugmakers to recall certain products off the shelf in the latest effort to enforce good manufacturing practices (GMP) on the firms suspected of sending medicines to the market that failed origin, labelling, data and quality assessments.

BeiGene Presents Clinical Data for RAF Dimer Inhibitor BGB-283 at the 2016 American Association for Cancer Research Annual Meeting

TrendBeiGene2016-04-20 15:37 Read   95

BeiGene, Ltd. (NASDAQ:BGNE) (“BeiGene”), a clinical-stage biopharmaceutical company focused on developing molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced the presentation of initial clinical data from an ongoing Phase I clinical trial of BGB-283 in patients with BRAF or KRAS/NRAS-mutated cancers in the Clinical Trials Plenary Session at the 2016 American Association for Cancer Research (AACR) Annual Meeting in New Orleans, LA.

Protein Sciences Corporation, Sinergium Biotech and Mundo Sano Announce Zika Vaccine Partnership

Frontierprnewswire2016-04-20 14:28 Read   56

Protein Sciences Corporation announced today that they have entered into an agreement to become members of a consortium that will jointly develop a Zika virus vaccine to combat the recent outbreak of Zika that is wreaking havoc in Latin America and spreading to other continents.

FDA pulls approvals on AbbVie's ex-blockbuster heart meds

Regulatorfiercepharma2016-04-20 14:23 Read   116

Years after two AbbVie cholesterol-fighting combos were approved, the FDA has decided they shouldn’t be on the market.

China probes drugmakers over production methods

EVENTSreuters2016-04-20 14:19 Read   71

Three Chinese drugmakers are under investigation for crimes including using counterfeit medicines, the industry watchdog said, as China cracks down on shoddy practices in the world's second-biggest drugs market.